Related Experiment Video
Updated: Jan 9, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Current Standard for High-risk Upper Tract Urothelial Cancer: Platinum-based Chemotherapy-Proven, Not Postulated
1Rosemere Cancer Centre, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
Abstract:
Adjuvant chemotherapy is the standard of care for high-risk upper tract urothelial carcinoma after radical nephroureterectomy. Level 1 data and global guidelines confirm that this is the case, and adjuvant chemotherapy remains the option to beat in this setting.
More Related Videos
06:39Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Published on: November 22, 2019
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014